Per the Announcement on Implementing the Third Batch of Medical Device Unique Identification (UDI) (No. 22, 2023) jointly issued by the National Medical Products Administration, National Health Commission, and National Healthcare Security Administration, 15 categories (103 types) of Class II medical devices will implement UDI starting June 1. To assist Hunan-based enterprises, the Provincial Medical Products Administration and GS1 China co-hosted a public training session on UDI implementation in Changsha on May 23. Over 400 representatives from medical device manufacturers, distributors, and healthcare institutions attended, with nearly 10,000 viewers online.
The training covered UDI-related regulations, implementation processes, challenges, and timelines. GS1 China presented a one-stop UDI solution, while experts from Hunan APT Medical, China National Medical Devices (Wuhan Branch), and Xiangya Hospital shared insights on UDI application and testing. An interactive Q&A session addressed enterprise concerns, enhancing the quality management capabilities of attendees.
Next, the Provincial Medical Products Administration will guide enterprises to implement UDI as required, advancing life-cycle management and traceability of medical devices.
